Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:GRNA GreenLight Biosciences (GRNA) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About GreenLight Biosciences Stock (NASDAQ:GRNA) 30 days 90 days 365 days Advanced Chart Ad Investors AlleyThe #1 ETF for monthly incomeWe just found the #1 ETF for monthly income. This outlier is paying a huge 22% dividend... And you could start collecting it if you act by December 19th.Click here to get the full story >> Get GreenLight Biosciences alerts:Sign Up Key Stats Today's Range$0.30▼$0.3050-Day Range$0.30▼$0.3052-Week Range$0.18▼$5.90Volume732 shsAverage Volume486,986 shsMarket Capitalization$45.43 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewFUNR manufactures and sells all-natural juice beverages. Its products include pomegranate cranberry, wild berry and passion fruit-orange. The company was founded by Alex C. Procopio on July 22, 1980 and is headquartered in Las Vegas, NV.Read More… The #1 ETF for monthly income (Ad)We just found the #1 ETF for monthly income. This outlier is paying a huge 22% dividend... And you could start collecting it if you act by December 19th.Click here to get the full story >> Receive GRNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GreenLight Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address GRNA Stock News HeadlinesGreenlight Coupon CodesApril 21, 2024 | washingtonpost.comSplashdown Quaywest gets green light for £3m upgradeDecember 20, 2023 | bbc.comThe #1 ETF for monthly incomeWe just found the #1 ETF for monthly income. This outlier is paying a huge 22% dividend... And you could start collecting it if you act by December 19th.November 22, 2024 | Investors Alley (Ad)Broadwalk Shopping Centre redevelopment given green lightSeptember 28, 2023 | bbc.comGreenlight Family Cash Card 2023 ReviewSeptember 19, 2023 | forbes.comGreenLight Biosciences: GreenLight Announces Completion of Merger with Fall Line Endurance FundJuly 24, 2023 | finanznachrichten.deGreenLight Announces Completion of Merger with Fall Line Endurance FundJuly 24, 2023 | finance.yahoo.comGreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding SharesJuly 20, 2023 | finance.yahoo.comSee More Headlines GRNA Stock Analysis - Frequently Asked Questions What other stocks do shareholders of GreenLight Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that GreenLight Biosciences investors own include Sangamo Therapeutics (SGMO), Anavex Life Sciences (AVXL), Abrdn Asia-Pacific Income Fund (FAX), MSP Recovery (LIFW), MSP Recovery (LIFW), Meta Platforms (META) and NVIDIA (NVDA). Company Calendar Today11/22/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:GRNA CUSIPN/A CIK1822691 Webwww.eiacorp.com Phone(760) 809-8079FaxN/AEmployees280Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.14) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-167,050,000.00 Net Margins-1,521.00% Pretax Margin-1,510.44% Return on Equity-374.26% Return on Assets-122.78% Debt Debt-to-Equity Ratio0.49 Current Ratio1.21 Quick Ratio1.21 Sales & Book Value Annual Sales$10.20 million Price / Sales4.45 Cash FlowN/A Price / Cash FlowN/A Book Value$0.32 per share Price / Book0.94Miscellaneous Outstanding Shares151,681,000Free Float105,722,000Market Cap$45.43 million OptionableNot Optionable Beta1.44 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report This page (NASDAQ:GRNA) was last updated on 11/22/2024 by MarketBeat.com Staff From Our PartnersFinancial Prophecy The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored[Charles Payne Live Event] Click to Confirm Your RSVPThe Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about Unstoppable Prosperity | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | SponsoredA “Thank You Gift” From Pres. Trump - GeniusThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredThe #1 Bitcoin ETF For Monthly DividendsYou don't have to own any Bitcoin to collect BIG dividends from it... Now, thanks to this brand new Bitcoin...Investors Alley | Sponsored“Trump Trades” You’ve Got to MakeThese Stocks are the Best “Trump Trades” Free e-book reveals sectors – and stocks within them – likely to p...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GreenLight Biosciences Holdings Please log in to your account or sign up in order to add this asset to your watchlist. Share GreenLight Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
